(Q37432112)

20 August 2017

1 reference

title

Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders (English)

1 reference

20 August 2017

1 reference

Kenneth Freedman

1

1 reference

PubMed ID

19344248

20 August 2017

Jay Nathanson

series ordinal

2

1 reference

20 August 2017

1 April 2009

1 reference

Expert Review of Anti-infective Therapy

20 August 2017

1 reference

20 August 2017

7

1 reference

20 August 2017

3

1 reference

20 August 2017

363-376

1 reference

The five-site health and risk study of blood-borne infections among persons with severe mental illness.

20 August 2017

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities

21 January 2018

1 reference

Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?

21 January 2018

1 reference

Hepatitis C and HIV infections: implications for clinical care in injection drug users

21 January 2018

1 reference

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care

21 January 2018

1 reference

Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants

21 January 2018

1 reference

Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.

21 January 2018

1 reference

Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users

21 January 2018

1 reference

Interferon alpha-2a plus ribavirin 1,000/1,200 mg versus interferon alpha-2a plus ribavirin 600 mg for chronic hepatitis C infection in patients on opiate maintenance treatment: an open-label randomized multicenter trial.

21 January 2018

1 reference

A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance

21 January 2018

1 reference

Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse

21 January 2018

1 reference

21 January 2018

1 reference

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

21 January 2018

1 reference

Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.

21 January 2018

1 reference

Treatment for hepatitis C virus infection among current injection drug users in Australia

21 January 2018

1 reference

Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders

21 January 2018

1 reference

Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study

21 January 2018

1 reference

Hepatitis C in schizophrenia: screening experience in a community-dwelling clozapine cohort.

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

Psychiatric management of the hepatitis C patient.

21 January 2018

1 reference

Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C treatment for people with severe mental illness

21 January 2018

1 reference

Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients

21 January 2018

1 reference

Hepatitis C treatment eligibility and outcomes among patients with psychiatric illness

21 January 2018

1 reference

Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

21 January 2018

1 reference

Delivering care to injection drug users coinfected with HIV and hepatitis C virus

21 January 2018

1 reference

The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone

21 January 2018

1 reference

Approaching treatment for hepatitis C virus infection in substance users

21 January 2018

1 reference

Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.

21 January 2018

1 reference

Referral for chronic hepatitis C treatment from a drug dependency treatment setting.

21 January 2018

1 reference

Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.09.1

1 reference

20 August 2017

1 reference

PubMed ID

19344248